000			01717 a2200241 4500
003			OSt
020			_a9781782624240
040			_cIITK
041			_aeng
082			_a615.3 _bAn87
245			_aAntibiotic drug discovery _bnew targets and molecular entities _cedited by Steven M. Firestine and Troy Lister
260			_bThe Royal Society of Chemistry _c2017 _aLondon
300			_axv, 271p
440			_aDrug discovery series
490			_a / edited by David Thurston _vno. 58
505			_a
520			_aRecent years have seen a resurgence of antibiotic drug discovery. This book brings together the relevant information to assess the state-of-the-art. It identifies and elaborates the most recent and compelling strategies for antibiotic drug discovery with a primary focus on new targets, mechanisms and molecular entities. Addressing the need for continued investment in antibiotic drug development, the book provides a point of reference for the rapidly expanding infectious disease research community. In addition to its attention on new targets, the book focusses on the medicinal chemistry and chemistry of the targets. Within this framework, chapters from leading researchers in academia and industry address findings in important areas such as biofilm production, narrow spectrum antibiotics and novel antibacterials from previously uncultured soil bacteria. This book will be a useful resource for postgraduate students and researchers in medicinal chemistry wishing to understand the latest approaches to antibiotic drug discovery
650			_aAntibiotics research
650			_aDrug discovery
700			_aFirestine, Steven M. [ed.]
700			_aLister, Troy [ed.]
942			_cBK
999			_c557945 _d557945